4 Results for "

Zosuquidar

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Zosuquidar" in MCE Product Catalog:

16
16 Cited Publications
Cat. No.: HY-15255
CAS No.: 167354-41-8
Purity:  99.90%
Synonyms: RS 33295-198; LY-335979
Target:  

P-glycoprotein

Research Areas:  

Cancer

Zosuquidar (LY335979) is a P-glycoprotein (P-gp) inhibitor (Ki=59 nM). Zosuquidar shows anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-50671
CAS No.: 167465-36-3
Synonyms: RS 33295-198 trihydrochloride; LY-335979 trihydrochloride
Target:  

P-glycoprotein

Research Areas:  

Cancer

Zosuquidar (LY335979) trihydrochloride is a P-glycoprotein (P-gp) inhibitor (Ki=59 nM). Zosuquidar trihydrochloride shows anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research .
loading...
    loading...
Cat. No.: HY-50671R
CAS No.: 167465-36-3
Synonyms: RS 33295-198 trihydrochloride (Standard); LY-335979 trihydrochloride (Standard)
Research Areas:  

Cancer

Zosuquidar (trihydrochloride) (Standard) is the analytical standard of Zosuquidar (trihydrochloride). This product is intended for research and analytical applications. Zosuquidar (LY335979) trihydrochloride is a P-glycoprotein (P-gp) inhibitor (Ki=59 nM). Zosuquidar trihydrochloride shows anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research .
loading...
    loading...
Cat. No.: HY-182342
CAS No.: 3109982-48-8
Target:  

SGK

Research Areas:  

Neurological Disease

SGK1-IN-8 (compound 55) is a SGK1 and GSK3β inhibitor, with an IC50 of 0.11 μM against human SGK1 and an IC50 of 3.39 μM against human GSK3β. SGK1-IN-8 inhibits the catalytic activities of SGK1 and GSK3β, and reduces the phosphorylation level of TAU protein at the Ser214 site. SGK1-IN-8 is available for the research of Alzheimer's disease .
loading...
    loading...